Compound Summary
Compound Information
L-Cycloserine
Compound Name: | L-Cycloserine |
Compound CID: | 449215 |
Synonyms: | L-Cycloserine 339-72-0 Levcycloserine (S)-4-Aminoisoxazolidin-3-one Levcicloserina More... |
Iupac Name: | (4S)-4-amino-1,2-oxazolidin-3-one |
InChI: | InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m0/s1 |
InChIKey: | DYDCUQKUCUHJBH-REOHCLBHSA-N |
Canonical Smiles: | C1C(C(=O)NO1)N |
Isomeric Smiles: | C1[C@@H](C(=O)NO1)N |
Molecular Weight: | 102.09 |
Molecular Formula: | C3H6N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-Cycloserine
Molecular Weight: | 102.09 |
Molecular Formula: | C3H6N2O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 7 |
Complexity: | 92.9 |
Synonyms
L-Cycloserine
| L-Cycloserine | L-Cycloserine |
|---|---|
L-Cycloserine |
339-72-0 |
Levcycloserine |
(S)-4-Aminoisoxazolidin-3-one |
Levcicloserina |
Levcycloserinum |
(4S)-4-amino-1,2-oxazolidin-3-one |
Cyclo-L-serine |
UNII-AK7DRB7FMO |
(S)-(-)-Cycloserine |
(-)-cycloserine |
L-4-Aminoisoxazolidin-3-one |
(S)-4-Amino-3-isoxazolidone |
(S)-4-Amino-3-isoxazolidinone |
AK7DRB7FMO |
L-4-Amino-3-isoxazolidinone |
CHEBI:75592 |
(4S)-4-aminoisoxazolidin-3-one |
L-Oxamicina |
4-azaniumyl-4,5-dihydro-1,2-oxazol-3-olate |
L-Oxamicina Italian |
Levcycloserine USAN:INN |
Levcycloserinum INN-Latin |
Levcicloserina INN-Spanish |
L-Cycloserin |
(-)-4-Amino-3-isossazolidone |
(S)-Cycloserine |
EINECS 206-427-0 |
3-Isoxazolidinone, 4-amino-, (4S)- |
BRN 0080799 |
(-)-4-Amino-3-isossazolidone Italian |
L-CS |
Prestwick0_001086 |
Prestwick1_001086 |
Prestwick2_001086 |
Prestwick3_001086 |
Levcycloserine (USAN/INN) |
Lopac0_000199 |
BSPBio_001132 |
4-27-00-05550 (Beilstein Handbook Reference) |
MLS000859981 |
SCHEMBL243772 |
SPBio_003026 |
BPBio1_001246 |
CHEMBL448864 |
GTPL9488 |
(-)-4-amino-3-isoxazolidinone |
(-)-4-aminoisoxazolidin-3-one |
(S)-4-amino-isoxazolidin-3-one |
DTXSID701017231 |
HMS1571I14 |
HMS2098I14 |
HMS2235N07 |
HMS3260H19 |
HMS3264E06 |
HMS3715I20 |
(S)-3-Isoxazolidinone, 4-amino- |
4AX |
ACT10801 |
HY-B1122 |
Tox21_500199 |
4034AB |
BDBM50357231 |
FD3007 |
MFCD00064324 |
s3945 |
SBB006706 |
ZINC34676244 |
3-Isoxazolidinone, 4-amino-, (S)- |
AKOS006237181 |
CCG-204294 |
CS-4717 |
LP00199 |
NSC 760409 |
SDCCGSBI-0050187.P002 |
NCGC00093674-01 |
NCGC00093674-02 |
NCGC00093674-03 |
NCGC00093674-04 |
NCGC00093674-07 |
NCGC00093674-08 |
NCGC00260884-01 |
DS-18395 |
SMR000326840 |
AB0006204 |
AB00514038 |
EU-0100199 |
L-Cycloserine, L-4-Amino-3-isooxazolidinone |
3-ISOXAZOLIDINONE, 4-AMINO-, (L)- |
(4S)-4-amino-2,4,5-trihydroisoxazol-3-one |
(S)-4-Amino-3-isoxazolidone;(S)-Cycloserine |
C 1159 |
D04706 |
AB00514038_05 |
339C720 |
SR-01000780566 |
J-502461 |
SR-01000780566-2 |
Q27145415 |
Experimental Data
L-Cycloserine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -1 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
L-Cycloserine
Statistics Data
L-Cycloserine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -1 | 1 | 1 |
Statistics Data Visualization
L-Cycloserine
